Islamabad: Speaker of the National Assembly, Sardar Ayaz Sadiq, extended his congratulations to the newly elected leaders of the Video
Islamabad: The Standing Committee on National Heritage and Culture has acknowledged the Ministry’s efforts in repatriating 1,252 archaeological artefacts from
ISLAMABAD: Speaker of the People’s Majlis of the Maldives, Abdul Raheem Abdulla, led a parliamentary delegation to the Parliament House
ISLAMABAD: The Pakistan-Maldives Parliamentary Friendship Group (PFG) engaged in a meeting with a visiting parliamentary delegation from the Republic of
New York: In a joint meeting held on the sidelines of the 81st Session of the United Nations General Assembly,
New York: The Foreign Ministers of Egypt, Pakistan, Saudi Arabia, and Türkiye convened in New York on the sidelines of
ISLAMABAD: The 8th Round of the Pakistan-France Joint Security Commission convened in Islamabad, with senior officials from both nations engaging
Islamabad: In a recent briefing by the Senate Standing Committee on Climate Change, Senator Sherry Rehman called for decisive measures
Mr. Oliveira is an accomplished biopharmaceutical industry executive with nearly 25 years of commercial experience, building high-performing teams, and launching multiple successful pharmaceutical products WALTHAM, Mass., July 01, 2024 (GLOBE NEWSWIRE) — Zenas BioPharma, a global biopharmaceutical company committed to becoming a leader in the development and commercialization of immunology-based
Miami, July 01, 2024 (GLOBE NEWSWIRE) — Miami, FL – July 1st , 2024. Aleph Group, the global leader in connecting leading global digital media platforms with advertisers and consumers in primarily emerging markets, today announced the completion of its acquisition of Entravision Global Partners (“EGP”), the digital commercial partnership
Nyxoah Submits Fourth and Final Module in PMA Application for Genio to the US FDA Mont-Saint-Guibert (Belgium), July 1, 2024, 8:00am CET / 2:00am ET – (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today
